Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Schroder UK Public Private Trust ( (GB:INOV) ).
Schroders Capital Global Innovation Trust PLC has announced its annual report and financial statements for the year ended 31 December 2024, revealing a strategic shift towards a managed wind-down of the company. This decision follows a shareholder vote in favor of the wind-down, aiming for an orderly realization of the company’s assets to maximize returns and return capital to shareholders. The report highlights a 21.2% drop in NAV per share and a 24.9% decrease in share price, with significant losses in its legacy portfolio. However, the company saw positive contributions from its investment in Revolut and made three new investments in venture, growth, and life sciences. The acquisition of Araris Biotech AG by Taiho Pharmaceutical Co. Ltd. is expected to generate significant returns, further impacting the company’s NAV positively.
More about Schroder UK Public Private Trust
Technical Sentiment Signal: Buy
Learn more about INOV stock on TipRanks’ Stock Analysis page.